Primary Care Diabetes Case Conference

Boston, MA US
November 4, 2022

This conference will focus on the use of glucagon-like peptide-1 (GLP1) receptor agonists and sodium-glucose co-transporter 2 (SGLT2) inhibitors as the standard of care in management of Type 2 Diabetes.  Drs. Deborah Wexler and Enrico Cagliero from the MGH Diabetes Center will review some of the most common questions they receive from Primary Care about the use of these medications with special emphasis on safety, managing side effects, and considerations for changing medications.

Attendees are encouraged to bring additional case studies for discussion as time allows.

Target Audience

This activity is intended for Primary Care Physicians and APPs within the Mass General Brigham system.

Learning Objectives

Upon completion of this activity, participants will be able to:

  1. Apply latest standards of care for Type 2 Diabets into their clinical practice.
  2. Describe functions and indications of SGLT-2 and GLP-1 classes of medication.
  3. Consider applications of novel diabetes medications in their clinical practice.
  4. Develop strategies for employing team-based care in managing Type 2 Diabetes.
  5. Identify opportunities to further integrate diabetes nurse teaching visits into regular operations.

Additional Information

Provided by: 

Massachusetts General Hospital & Mass General Brigham

Course summary
Available credit: 
  • 2.25 AMA PRA Category 1 Credit™
  • 2.25 Nursing
  • 2.25 Participation
Course opens: 
09/20/2022
Course expires: 
12/04/2022
Event starts: 
11/04/2022 - 1:30pm EDT
Event ends: 
11/04/2022 - 4:30pm EDT
Cost:
$0.00
1:30pmRegistration
2:00Opening Remarks | Daniel Horn, MD & Julie Marden, NP
2:15

SGLT2s and GLP-1s as Standard of Care in Diabetes Management  | Deborah Wexler, MD & Enrico Cagliero, MD

  • Safety warnings and managing side effects
  • Use of SGLT2/GLP-1 by patients with kidney failure
  • Considerations for changing medications
  • Navigating insurance coverage
3:00Q&A
3:30BREAK
3:45Additional Q&A/Case Study Discussion
4:30pmAdjourn

 

Wyndham Boston Beacon Hill
5 Blossom St.
Boston, MA 02114
United States

Daniel M. Horn - Course Director
Primary Care Physician,
Director, Population Health and Quality,
Division Of General Internal Medicine
Massachusetts General Hospital;
Associate Medical Director,
Massachusetts General Physicians Organization;
Assistant Professor of Medicine, Harvard Medical School

Enrico Cagliero, MD
Physician,
Director, Inpatient Diabetes Service,
Quality and Safety Director, Endocrinology Division,
Member of the MGH Diabetes Center,
Massachusetts General Hospital;
Associate Professor of Medicine, Harvard Medical School

Julie Marden MSN NP-BC
Director of Advanced Practice Providers and Nursing,
Primary Care, DGIM, 
Massachusetts General Hospital

Deborah J. Wexler, MD, MSc
Clinical Director, MGH Diabetes Center,
Massachusetts General Hospital;
Associate Professor, Harvard Medical School

 

In support of improving patient care, Mass General Brigham is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Credit Designation Statements

AMA PRA Category 1 Credit™.
Mass General Brigham designates this live activity for a maximum of 2.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Nursing
Mass General Brigham designates this activity for 2.25 ANCC contact hours. Nurses should only claim credit commensurate with the extent of their participation in the activity.

 

Available Credit

  • 2.25 AMA PRA Category 1 Credit™
  • 2.25 Nursing
  • 2.25 Participation

Price

Cost:
$0.00
Please login or register to take this course.